November 23, 2008
At work
Oh well, I heard from my manager last week that our functionalities increased
tremendously. I will need to strategize the robust e-commerce. Sigh. K. heard
that the EDI account has become profitable.
Yesterday's lunch
Yesterday K. took me to a tiny Mexican restaurant called Carlos. K. took charge
of ordering the menu. After studying the menu for a few minutes I decided on the tamale. K. really enjoyed the excellent frijoles.
We enjoyed the afternoon. You should go there if you're in the neighbourhood.
Insanely busy...
I was indeed too busy to post or even to read blogs. There aren't enough hours
in the day. I had all this work to do. I 've been working continously. There
aren't enough hours in the day. It seems like it is a crying shame. Tired and
weary all week
November 21, 2008
Work
Today K. told me that I'm not going to keep working on the MicroPlan account
and have to modify stuff for the MicroPlan. My work day is full of
interruptions. I'm not going to cancel the MicroPlan test and have to attend some seminar.
Dinner
Yesterday I had dinner with K., we first considered Mother Earth Oasis but
decided on Green Vegetarian. It was crowded. We had to wait for 15 minutes
before we could get a table. A colleague recommended it to K.. K. had the tofu scramble, wheat protein and tofu scramble, I had a hard time deciding on the menu, because everything looked spicy, but finally decided to go with the bbq seitan sandwich.
I had a great time. I recommend Green Vegetarian to everyone.
November 20, 2008
Too busy...
I haven't blogged for a while, but I have been too occupied all week. I'm
running on fumes but I don't give up. Just no time to blog. It seems like it is
a crying shame. Exhausted and tired.
November 17, 2008
This is just in: Microsoft, Yahoo execs finally meet
Scripps News is reporting: Yahoo. chief playing for survival.
Panel Seeks New Limits on Anemia Drugs
New York Times says: Panel Seeks New Limits on Anemia DrugsShares of Amgen retreated early Friday, a day after a regulatory panel advised restricting use of the biotech's drugs used for chemotherapy-induced anemia.

